Antibiotic Resistance in the Environment : A Worldwide Overview / / edited by Célia M. Manaia, Erica Donner, Ivone Vaz-Moreira, Peiying Hong |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
Descrizione fisica | 1 online resource (XII, 344 p. 1 illus.) |
Disciplina | 616.9041 |
Collana | The Handbook of Environmental Chemistry |
Soggetto topico |
Environmental chemistry
Pharmacology Microbiology Pharmacovigilance Medical microbiology Environmental Chemistry Drug Safety and Pharmacovigilance Medical Microbiology Resistència als medicaments Efecte dels medicaments sobre els microorganismes Química ambiental |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-55065-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Antibiotic resistance in the environment: expert perspectives -- Antibiotic resistant bacteria in wildlife -- Genomic surveillance for One Health antimicrobial resistance: understanding human, animal, and environmental reservoirs and transmission -- Antibiotic resistance in pharmaceutical industry effluents and effluent-impacted environments -- Antibiotic resistance in municipal wastewater: A special focus on hospital effluents -- Control strategies to combat dissemination of antibiotic resistance in urban water systems -- Antibiotic resistance, sanitation and public health -- Antibiotic resistance and sanitation in India: current situation and future perspectives -- Mitigating antimicrobial resistance risks when using reclaimed municipal wastewater for agriculture -- Antibiotic resistance in soil -- Religious Mass Gathering (Hajj) and Antimicrobial Resistance: From Challenges to Opportunities -- Human movement and transmission of anti-microbial resistant bacteria. |
Record Nr. | UNINA-9910416142403321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Antitargets and drug safety / / edited by Lásló Urbán, Vinod F. Patel, and Roy J. Vaz |
Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH, , [2015] |
Descrizione fisica | 1 online resource (1266 p.) |
Disciplina | 615.19 |
Collana | Methods and principles in medicinal chemistry |
Soggetto topico |
Drugs - Side effects
Drugs - Side effects - Prevention Drug interactions Drug development Drugs - Structure-activity relationships Drug-Related Side Effects and Adverse Reactions Protein Kinase Inhibitors - adverse effects Pharmacovigilance |
ISBN |
3-527-67364-4
3-527-67366-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | section 1. General concept for target-based safety assessment -- section 2. Hepatic side effects -- section 3. Cardiovascular side effects -- section 4. Kinase antitargets -- section 5. Examples of clinical translation. |
Record Nr. | UNINA-9910132261703321 |
Weinheim, Germany : , : Wiley-VCH, , [2015] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Antitargets and drug safety / / edited by Lásló Urbán, Vinod F. Patel, and Roy J. Vaz |
Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH, , [2015] |
Descrizione fisica | 1 online resource (1266 p.) |
Disciplina | 615.19 |
Collana | Methods and principles in medicinal chemistry |
Soggetto topico |
Drugs - Side effects
Drugs - Side effects - Prevention Drug interactions Drug development Drugs - Structure-activity relationships Drug-Related Side Effects and Adverse Reactions Protein Kinase Inhibitors - adverse effects Pharmacovigilance |
ISBN |
3-527-67364-4
3-527-67366-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | section 1. General concept for target-based safety assessment -- section 2. Hepatic side effects -- section 3. Cardiovascular side effects -- section 4. Kinase antitargets -- section 5. Examples of clinical translation. |
Record Nr. | UNINA-9910823349403321 |
Weinheim, Germany : , : Wiley-VCH, , [2015] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Comprehensive Healthcare Simulation: Pharmacy Education, Practice and Research [[electronic resource] /] / edited by Yaser Mohammed Al-Worafi |
Autore | Al-Worafi Yaser Mohammed |
Edizione | [1st ed. 2023.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
Descrizione fisica | 1 online resource (278 pages) |
Disciplina | 615.10711 |
Collana | Comprehensive Healthcare Simulation |
Soggetto topico |
Pharmacy
Pharmacology Pharmacovigilance Public health administration Drug Safety and Pharmacovigilance Health Administration |
ISBN | 3-031-33761-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I. Simulation in Pharmacy Education -- Overview of Simulation in Pharmacy Education -- Patient simulation in Pharmacy Education -- Fidelity simulation in Pharmacy Education -- Computer-based Simulation in Pharmacy Education -- Simulation for Introductory Pharmacy Practice Experience (IPPE) -- Simulation for Advanced Pharmacy Practice Experience (APPE) -- Simulation for Pharmacotherapy -- Simulation for Clinical Pharmacokinetics -- Simulation for Medication Safety -- Simulation for Pharmacology -- Simulation for Pharmaceutical Chemistry -- Simulation for Pharmaceutics and Pharmaceutical Industry -- Simulation for Drug Information and Poisons Services -- Simulation for Complementary and Alternative Medicines and Nutraceuticals -- Simulation for personalized medicine -- Simulation for Clinical Toxicology and Forensic Medicine -- In situ and mobile simulation in pharmacy education -- Facilitators of Simulation in Pharmacy Education -- Barriers of Simulation in Pharmacy Education -- Assessment, Evaluation and Feedback of Simulation in Pharmacy Education -- Effectiveness of simulation in pharmacy education -- Quality standards and recommendations of the simulation in pharmacy education -- Simulation training -- Part II. Simulation for Pharmacy Practice -- Overview of Simulation in Pharmacy Practice -- Simulation in Community Pharmacy Practice -- Simulation in Hospital Pharmacy Practice -- Simulation for communication skills assessment -- Simulation in patient care -- Simulation in the distance and online pharmacy practice: telepharmacy and telehealth -- Simulation for medication safety and patient safety practice -- Assessment, Evaluation and Feedback of Simulation in Pharmacy Practice -- Facilitators of Simulation in Pharmacy Practice -- Barriers of Simulation in Pharmacy Practice -- Quality standards and recommendations of Simulation in Pharmacy Practice -- Part III. Simulation for Pharmacy Research -- Overview of Simulation in Pharmacy Research -- Simulation for Drug Development -- Design simulation-based research in pharmacy -- Recruiting and train the simulated patients/persons -- Data analysis -- Ethics in simulation research -- Simulation research reports and publication -- Facilitators of simulation research -- Barriers of simulation research. |
Record Nr. | UNINA-9910736020703321 |
Al-Worafi Yaser Mohammed
![]() |
||
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Current chemical genomics and translational medicine |
Pubbl/distr/stampa | Sharjah, U.A.E : , : Bentham Open, , [2013]-[2018] |
Descrizione fisica | 1 online resource (6 volumes) |
Soggetto topico |
Genomics
Translational Research, Biomedical Pharmacoepidemiology Pharmacovigilance |
Soggetto genere / forma |
Fulltext
Internet Resources. Periodicals. |
ISSN | 2213-9885 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910132238603321 |
Sharjah, U.A.E : , : Bentham Open, , [2013]-[2018] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Current problems in pharmacovigilance / / Committee on Safety of Medicines [and] Medicines Control Agency |
Pubbl/distr/stampa | [London, : The Agency] |
Descrizione fisica | 1 online resource |
Soggetto topico |
Pharmacovigilance
Drug development - Standards Drugs - Quality control Pharmaceutical Preparations - adverse effects |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996197552403316 |
[London, : The Agency] | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Current problems in pharmacovigilance / / Committee on Safety of Medicines [and] Medicines Control Agency |
Pubbl/distr/stampa | [London, : The Agency] |
Descrizione fisica | 1 online resource |
Soggetto topico |
Pharmacovigilance
Drug development - Standards Drugs - Quality control Pharmaceutical Preparations - adverse effects |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910142821603321 |
[London, : The Agency] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cutaneous Drug Hypersensitivity : Clinical Features, Mechanisms, Diagnosis, and Management / / edited by Andreas J. Bircher, Howard I. Maibach, Knut Brockow, Annick Barbaud |
Edizione | [1st ed. 2022.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
Descrizione fisica | 1 online resource (346 pages) |
Disciplina | 615.778 |
Soggetto topico |
Dermatology
Allergy Internal medicine Pharmacovigilance Primary care (Medicine) Family medicine Allergology Internal Medicine Drug Safety and Pharmacovigilance Primary Care Medicine General Practice and Family Medicine Medicaments dermatològics Efectes secundaris dels medicaments |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-82743-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I. General aspects of drug hypersensitivity -- Chapter 1. Terminology, classifications, chronology -- Chapter 2. Epidemiology -- Chapter 3. Clinical manifestations: Cutaneous signs and syndromes -- Chapter 4. Clinical manifestations: Other organs (kidney, gut, heart, brain etc.) -- Chapter 5. Danger signs in drug hypersensitivity and severity SCORES -- Chapter 6. Pathomechanisms in Drug Hypersensitivities -- Part II. Diagnostic methods -- Chapter 7. Skin tests -- Chapter 8. Serological tests -- Chapter 9. T cell tests -- Chapter 10. Basophil activation tests -- Chapter 11. Histopathology of drug induced exanthemas -- Part III. Management -- Chapter 12. Drug desensitization in immediate-type hypersensitivity -- Chapter 13. Documentation allergy card/pass -- Part IV. Drug hypersensitivity in specific populations -- Chapter 14. Children and Adolescents -- Chapter 15. HIV-Infection and AIDS -- Chapter 16. Oncology. immune checkpoint Inhibitors -- Chapter 17. MC releasing syndromes in drug hypersensitivity -- Part V. Eliciting Drugs -- Chapter 18. Penicillins -- Chapter 19. Cephalosporin Allergy -- Chapter 20. Other Antibiotics -- Chapter 21. Other Antiinfectious drugs -- Chapter 22. Analgesics and non-steroidal antiphlogistic drugs -- Chapter 23. Periinterventional hypersensitivity: Anesthetic drugs and materials -- Chapter 24. Muscle relaxants -- Chapter 25. Anticoagulants -- Chapter 26. Biological drugs -- Chapter 27. Hormones (delayed) -- Chapter 28. Vaccines -- Chapter 29. Antiepileptic and psychotropic drugs -- Chapter 30. PROTON PUMP INHIBITORS -- Chapter 31. Diagnostic agents -- Chapter 32. Hypersensitivity to blood pressure agents -- Chapter 33. Iron preparations -- Chapter 34. Vitamins and supplements -- Chapter 35. Anti-tumor drugs / Cytostatics -- Chapter 36. Photosensitizing drugs -- Chapter 37. Topically applied drugs -- Chapter 38. Additives: Preservatives, Antioxidants (sulfites), Colors, dyes and other. |
Record Nr. | UNINA-9910768200103321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Ethical Innovation for Global Health [[electronic resource] ] : Pandemic, Democracy and Ethics in Research / / edited by Chieko Kurihara, Dirceu Greco, Ames Dhai |
Autore | Kurihara Chieko |
Edizione | [1st ed. 2023.] |
Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
Descrizione fisica | 1 online resource (331 pages) |
Disciplina | 174.2 |
Altri autori (Persone) |
GrecoDirceu
DhaiAmes |
Soggetto topico |
Medical Ethics
Bioethics Pharmacovigilance Medical policy Pharmaceutical chemistry Drug Safety and Pharmacovigilance Health Policy Pharmaceutics |
ISBN | 981-9961-63-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1 Introduction to Ethical innovation for global health: pandemic, democracy and ethics in research. Part 1 Relevant constructions from a middle-income country (MIC) and/or non-Western paradigms: Brazil, South Africa, Taiwan, South Korea, and Japan -- 2 Democracy restoration in Brazil, the constitutional guarantee of health as a right for all, giving rise to a universal health system (SUS) and of a National Research Ethics Commission -- 3 Equitable access to COVID-19 vaccines, vaccine research and Vaccine Apartheid on the African continent: challenges and recommendations -- 4 Response to Covid-19 pandemic and Ethical Innovations in Taiwan -- 5 Between truth and profit: Scientific misconduct case of human cloned embryonic stem cell and revisiting cases during COVID-19 pandemic -- 6 Therapeutic misconception as the basis for vaccine nationalism of Japan: a historical reflection and perspectives for global public health -- Part 2 Historical and international perspectives on the development of ethical principles in research involving humans -- 7 The Declaration of Helsinki as a living document: Revisiting its principles in a global pandemic -- 8 Hidden Medical War Crimes and the Emergence of Bioethics in Japan -- 9 From Nuremberg to Helsinki: Historicizing the Codification of Post-War Research Ethics -- 10 CIOMS research guidelines: Considering the needs of developing countries -- 11 Ethics of placebo-controlled trial: historical analysis including the experience of COVID-19 pandemic -- 12 Post-trial access: historical analysis considering the experience of COVID-19 pandemic -- 13 Our “WMA Declaration of Helsinki”: opinions and pro-posals from patient and public for research ethics -- Part 3 Alternative frameworks for innovation and drug development strategies -- 14 Medicines development for global health: Learning from COVID-19 vaccines R&D -- 15 Development of portfolios and pipelines of drugs for the treatment, prevention and control of neglected tropical diseases -- 16 Patient and Public Involvement (PPI) and pharmaceutical development through Open Innovation Processes ~ recent activities. |
Record Nr. | UNINA-9910765490203321 |
Kurihara Chieko
![]() |
||
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Extemporaneous Ophthalmic Preparations / / by Eman Ali Saeed Alghamdi, Abdulmalik Yahya Al Qahtani, Mazen M. Sinjab, Khalid Mohammed Alyahya |
Autore | Alghamdi Eman Ali Saeed |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
Descrizione fisica | 1 online resource (116 pages) |
Disciplina | 617.7061 |
Soggetto topico |
Ophthalmology
Pharmacy Pharmacovigilance Pharmacology Drug Safety and Pharmacovigilance |
ISBN | 3-030-27492-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Section 1: Introduction to Extemporaneous Ophthalmic Preparations -- Chapter 1 Ocular Pharmacokinetics -- Chapter 2 Factors Affecting Bioavailability and Efficacy of Topical Eye Preparations -- Chapter 3 Ideal Characteristics of Ophthalmic Drug Delivery System -- Chapter 4 Inert Substances Used in the Proration of Ophthalmic Products -- Chapter 5 Preservatives Used in Ophthalmic Preparations -- Section 2: Extemporaneous Topical Ophthalmic Formulations -- Chapter 6 Topical Ophthalmic Drug Forms -- Chapter 7 Extemporaneous Compounding of Ophthalmic Products -- Chapter 8 American Society of Hospital Pharmacists (ASHP) Guidelines on Pharmacy-Prepared Ophthalmic Products -- Chapter 9 Formulations of Extemporaneous Topical Ophthalmic Preparations -- Chapter 10 Extemporaneous Ophthalmic Preparations in Ocular Oncology -- Section 3: Extemporaneous Intraocular Injections. Chapter 11 Extemporaneous Intravitreal Injections -- Chapter 12 Extemporaneous Intracameral Injections -- Chapter 13 Formulations of Extemporaneous Intraocular Injections -- Section 4: Extemporaneous Sub Conjunctival Injections -- Chapter 14 Equipment -- Chapter 15 Steps for subconjunctival injections -- Chapter 16 Formulations of Extemporaneous Intraocular Injections. |
Record Nr. | UNINA-9910373946603321 |
Alghamdi Eman Ali Saeed
![]() |
||
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|